InsiderClue
Stocks · Health care · Pharmaceutical Preparations

PURPLE BIOTECH LTD.

PPBT Clue Score67
Israel Fiscal year ends December CIK 0001614744
$1.38 +3.76% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.38 −68.56% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 13 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−7.2Net income12.1Fiscal year 2017Revenue0.1Operating income−12.0Net income12.2 +0.4%Fiscal year 2018Revenue1.0 +900.0%Operating income−7.8Net income5.2 −57.3%Fiscal year 2019Revenue1.0 +0.0%Operating income−7.2Net income5.9 +12.5%Fiscal year 2020Revenue1.0 +0.0%Operating income−12.6Net income28.0 +378.6%Fiscal year 2021Operating income−17.9Net income18.4 −34.3%EPS, diluted17,568,036.00Fiscal year 2022Operating income−22.6Net income−21.7 −217.9%EPS, diluted23.97Fiscal year 2023Operating income−22.3Net income−19.9EPS, diluted17.96Fiscal year 2024Net income−7.2EPS, diluted4.99Fiscal year 2025Net income−26.4EPS, diluted0.03
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 0.1 1.0 1.0 1.0 n/a n/a n/a n/a n/a
Growth +900.0% +0.0% +0.0%
Operating income −7.2 −12.0 −7.8 −7.2 −12.6 −17.9 −22.6 −22.3 n/a n/a
Net income 12.1 12.2 5.2 5.9 28.0 18.4 −21.7 −19.9 −7.2 −26.4
Growth +0.4% −57.3% +12.5% +378.6% −34.3% −217.9%
EPS, diluted n/a n/a n/a n/a n/a 17,568,036.00 23.97 17.96 4.99 0.03

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Fiscal year 2017Operating margin−11,966.0%Net margin12,177.0%Free cash flow margin−8,640.0%Fiscal year 2018Operating margin−782.6%Net margin520.0%Free cash flow margin−849.6%Fiscal year 2019Operating margin−715.6%Net margin585.0%Free cash flow margin−197.9%Fiscal year 2020Operating margin−1,261.2%Net margin2,799.9%Free cash flow margin154.9%Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a −11,966.0% −782.6% −715.6% −1,261.2% n/a n/a n/a n/a n/a
Net margin n/a 12,177.0% 520.0% 585.0% 2,799.9% n/a n/a n/a n/a n/a
Free cash flow margin n/a −8,640.0% −849.6% −197.9% 154.9% n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−6.3Capital expenditure−0.0Free cash flow−6.3Fiscal year 2017Operating cash flow−8.6Capital expenditure−0.0Free cash flow−8.6Fiscal year 2018Operating cash flow−8.5Capital expenditure−0.0Free cash flow−8.5Fiscal year 2019Operating cash flow−2.0Capital expenditure−0.0Free cash flow−2.0Fiscal year 2020Operating cash flow1.7Capital expenditure−0.2Free cash flow1.5Fiscal year 2021Operating cash flow−0.4Capital expenditure−0.1Free cash flow−0.5 −131.6%Fiscal year 2022Operating cash flow−16.7Capital expenditure−0.0Free cash flow−16.8Fiscal year 2023Operating cash flow−19.9Capital expenditure−0.0Free cash flow−19.9Fiscal year 2024Operating cash flow−14.4Fiscal year 2025Operating cash flow−5.7Capital expenditure−0.0Free cash flow−5.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −6.3 −8.6 −8.5 −2.0 1.7 −0.4 −16.7 −19.9 −14.4 −5.7
Capital expenditure −0.0 −0.0 −0.0 −0.0 −0.2 −0.1 −0.0 −0.0 n/a −0.0
Free cash flow −6.3 −8.6 −8.5 −2.0 1.5 −0.5 −16.8 −19.9 n/a −5.7
Growth −131.6%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash6.8Shareholders’ equity13.4Fiscal year 2017Cash3.9Shareholders’ equity7.4Fiscal year 2018Cash5.2Shareholders’ equity10.5Fiscal year 2019Cash4.4Shareholders’ equity10.4Fiscal year 2020Cash11.2Shareholders’ equity79.4Fiscal year 2021Cash10.9Shareholders’ equity64.8Fiscal year 2022Cash15.0Shareholders’ equity46.9Fiscal year 2023Cash14.5Shareholders’ equity34.2Fiscal year 2024Cash7.4Shareholders’ equity32.9Fiscal year 2025Cash8.7Shareholders’ equity9.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 6.8 3.9 5.2 4.4 11.2 10.9 15.0 14.5 7.4 8.7
Shareholders’ equity 13.4 7.4 10.5 10.4 79.4 64.8 46.9 34.2 32.9 9.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
n/a −11,966.0% −782.6% −715.6% −1,261.2% n/a n/a n/a n/a n/a
n/a 12,177.0% 520.0% 585.0% 2,799.9% n/a n/a n/a n/a n/a
n/a −8,640.0% −849.6% −197.9% 154.9% n/a n/a n/a n/a n/a
Spending
n/a 4,640.0% 526.8% 227.8% 723.8% n/a n/a n/a n/a n/a
n/a 6,397.0% 519.5% 439.3% 600.1% n/a n/a n/a n/a n/a
n/a 13.0% 1.6% 1.1% 15.6% n/a n/a n/a n/a n/a
Returns
90.6% 164.4% 49.4% 56.1% 35.3% 28.4% −46.2% −58.1% −22.0% −271.6%
81.3% 85.9% 35.3% 39.7% 33.4% 26.2% −39.7% −44.9% −19.5% −150.2%